Success Metrics

Active Trials
2(40%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Other(2)

Detailed Status

Recruiting2
unknown2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting240%
unknown240%
enrolling_by_invitation120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
5